Treatment of obesity in Diabetes Mellitus type 1
DOI:
https://doi.org/10.47196/diab.v53i2Sup.231Keywords:
obesity, diabetesAbstract
The increase in the prevalence of obesity in type 1 diabetes mellitus (DM1) is alarming and is associated with insulin resistance similar to that observed in DM2, which led to its being considered “double diabetes”. Currently 50% of patients with DM1 are overweight or obese. Also the association with obesity has generated the development of dyslipidemia and macrovascular complications. Comorbidities associated with obesity reduce the benefits of good metabolic control, which is why the objective of the normal weight is important. The chronic and sustained pro-ammatory state of obesity is associated with cardiovascular disease.
References
- Corbin KD, Driscoll KA, Pratley RE, Smith SR, Maahs DM, Mayer-Davis EJ; Advancing Care for Type 1 Diabetes and Obesity Network (ACT1ON). Obesity in type 1 diabetes: pathophysiology, clinical impact, and mechanisms. Endocrine Reviews 2018; 39: 629-663.
- Polskya S, Ellisb SL. Obesity, insulin resistance, and type 1 diabetes mellitus. Curr Opin Endocrinol Diabetes Obes 2015; 22:277-282.
- Mottalib A, Kasetty M, Mar JY, Elseaidy T, Ashrafzadeh S, Hamdy O. Weight management in patients with type 1 diabetes and obesity. Curr Diab Rep 2017 Aug 23; 17(10):92. Doi: 10.1007/s11892-017-0918-8.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Dirección Nacional de Derecho de Autor, Exp. N° 5.333.129. Instituto Nacional de la Propiedad Industrial, Marca «Revista de la Sociedad Argentina de Diabetes - Asociación Civil» N° de concesión 2.605.405 y N° de disposición 1.404/13.
La Revista de la SAD está licenciada bajo Licencia Creative Commons Atribución – No Comercial – Sin Obra Derivada 4.0 Internacional.
Por otra parte, la Revista SAD permite que los autores mantengan los derechos de autor sin restricciones.
